未登录.png)
分享.png)
收藏分享 收藏 REAL-WORLD TREATMENT PATTERNS AND SURVIVAL OUTCOMES IN METASTATIC UROTHELIAL CARCINOMA IN THE ENFORTUMAB VEDOTIN ERA: IMPACT OF FIRST-LINE ENFORTUMAB VEDOTIN PLUS PEMBROLIZUMAB VERSUS PLATINUM CHEMOTHERAPY恩夫图木单抗时代转移性尿路上皮癌的真实世界治疗模式与生存结局：恩夫图木单抗联合帕博利珠单抗与铂类化疗一线治疗的比较影响
Kawashima, Atsunari; Ujike, Takeshi; Hayashi, Yujiro; Higaki, Ayuko; Nakano, Kosuke; Osaki, Hiroki; Sekii, Yosuke; Tsutsui, Kenji; Matsushita, Makoto; Imanaka, Takehiro; Okada, Koichi; Asakura, Toshihisa; Kurahashi, Yutaka; Horitani, Hiromu; Horibe, Yuki; Inoguchi, Shunsuke; Nakayama, Jiro; Nakayama, Masashi; Sato, Mototaka; Takao, Tetsuya; Yazawa, Koji; Takayama, Hitoshi; Takada, Tsuyoshi; Inoue, Hitoshi; Kobayashi, Masao; Nishimura, Kensaku; Kakimoto, Kenichi; Kishikawa, Hidefumi; Ishizuya, Yu; Hayashi, Takuji; Yamamoto, Yoshiyuki; Kato, Taigo; Hatano, Koji; Nonomura, Norio 分享 收藏 分享 收藏 JAVEMACS: a real-world study of avelumab maintenance therapy for advanced urothelial carcinoma in JapanJAVEMACS：一项在日本进行的avelumab维持治疗晚期尿路上皮癌的真实世界研究Kitamura, H.; Kobayashi, T.; Endo, Y.; Ikeda, M.; Yonemori, K.; Nakayama, M.; Fujihara, A.; Abe, T.; Shimizu, F.; Fujimoto, K.; Nakagawa, T.; Hatakeyama, S.; Murakami, K.; Nishihara, K.; Ikarashi, D.; Masumori, N.; Naito, S.; Fujita, K.; Hayakawa, N.; Hara, T.; Miura, N.; Negishi, T.; Yatsuda, J.; Kobayashi, M.; Nishiyama, N.; Taoka, R.; Furukawa, J.; Shono, M.; Shirotake, S.; Kikuchi, E. 分享 收藏 分享 收藏 Long-term changes in the chemical, microstructural, and transport properties of a low-pH cement shotcrete during operation of the Horonobe Underground Research Laboratory, Japan在日本幌延地下研究所运行期间，低pH水泥喷射混凝土的化学、微观结构和传输性能的长期变化Mochizuki, Akihito; Matsui, Hiroya; Nakayama, Masashi; Sakamoto, Ryo; Shibata, Masahito; Motoshima, Takayuki; Jo, Mayumi 分享 收藏 The prognostic impact of peripheral blood eosinophil counts in metastatic renal cell carcinoma patients treated with nivolumabYoshimura, Akihiro; Nagahara, Akira; Ishizuya, Yu; Yamamoto, Yoshiyuki; Hatano, Koji; Kawashima, Atsunari; Nakai, Yasutomo; Nakayama, Masashi; Nishimura, Kazuo; Nonomura, Norio; Kato, Taigo 分享 收藏 Clinical outocomes of nivolumab plus ipilimumab in metastatic renal cell carinomaKato, Taigo; Fujita, Kazutoshi; Nagahara, Akira; Nakata, Wataru; Matsuzaki, Kyousuke; Hatano, Koji; Kawashima, Atsunari; Takada, Shingo; Nishimura, Kensaku; Tsujihata, Masao; Takao, Tetsuya; Nakai, Yasutomo; Nakayama, Masashi; Nishimura, Kazuo; Uemura, Motohide; Uemura, Hirotsugu; Nonomura, Norio 分享 收藏 IMAGENE trial: multicenter, proof-of-concept, phase II study evaluating the efficacy and safety of combination therapy of niraparib with PD-1 inhibitor in solid cancer patients with homologous recombination repair genes mutationKato, Taigo; Matsubara, Nobuaki; Shiota, Masaki; Eto, Masatoshi; Osawa, Takahiro; Abe, Takashige; Shinohara, Nobuo; Yasumizu, Yota; Tanaka, Nobuyuki; Oya, Mototsugu; Nishimoto, Koshiro; Hayashi, Takuji; Nakayama, Masashi; Kojima, Takahiro; Namikawa, Kenjiro; Fujisawa, Takao; Okano, Susumu; Hida, Eisuke; Nakamura, Yoshiaki; Bando, Hideaki; Yoshino, Takayuki; Nonomura, Norio 分享 收藏 Clinical outcomes of tyrosine kinase inhibitors immediately after immune checkpoint inhibitors in renal cell carcinomaKato, Taigo; Nagahara, Akira; Kawamura, Norihiko; Nakata, Wataru; Soda, Tetsuji; Matsuzaki, Kyousuke; Hatano, Koji; Kawashima, Atsunari; Ujike, Takeshi; Nishimura, Kensaku; Takada, Shingo; Tsujihata, Masao; Yamaguchi, Seiji; Takao, Tetsuya; Nakai, Yasutomo; Nakayama, Masashi; Uemura, Motohide; Nonomura, Norio 分享 收藏 Updated analysis of circulating tumor DNA in advanced genitourinary cancers: SCRUM-Japan MONSTAR SCREEN ProjectNonomura, Norio; Kato, Taigo; Fujisawa, Takao; Shiota, Masaki; Eto, Masatoshi; Osawa, Takahiro; Abe, Takashige; Shinohara, Nobuo; Yasumizu, Yota; Tanaka, Nobuyuki; Oya, Mototsugu; Nishimoto, Koshiro; Hayashi, Takuji; Nakayama, Masashi; Horasawa, Satoshi; Kuramoto, Naomi; Nakamura, Yoshiaki; Bando, Hideaki; Yoshino, Takayuki; Matsubara, Nobuaki 分享 收藏 分享 收藏 分享 收藏 Residual Prostate Cancer Cells after Docetaxel Therapy Increase the Tumorigenic Potential via Constitutive Signaling of CXCR4, ERK1/2 and c-MycHatano, Koji; Yamaguchi, Souhei; Nimura, Keisuke; Murakami, Kouki; Nagahara, Akira; Fujita, Kazutoshi; Uemura, Motohide; Nakai, Yasutomo; Tsuchiya, Mutsumi; Nakayama, Masashi; Nonomura, Norio; Kaneda, Yasufumi 分享 收藏 分享 收藏 GENETIC POLYMORPHISMS OF CYP17A1 MAY PREDICT EARLY PROGRESSION AFTER PRIMARY ANDROGEN DEPRIVATION THERAPY IN JAPANESE MEN WITH PROSTATE CANCERNakayama, Masashi; Yamada, Takeshi; Shimizu, Tomohito; Nonen, Shinpei; Nishimura, Kensaku; Nishimura, Kazuo; Hara, Tsuneo; Tanigawa, Go; Yoshioka, Toshiaki; Hatano, Koji; Nakai, Yasutomo; Takayama, Hitoshi; Fujio, Yasushi; Azuma, Junichi; Okuyama, Akihiko; Nonomura, Norio 分享 收藏 ADJUVANT PLATINUM-BASED CHEMOTHERAPY IMPROVED THE PROGNOSIS OF PATIENTS WITH PT3N0/XM0 UPPER URINARY TRACT CARCINOMAKawashima, Atsunari; Nakai, Yasutomo; Nakayama, Masashi; Ujike, Takeshi; Tanigawa, Go; Takeda, Ken; Ono, Yutaka; Yoshioka, Toshiaki; Takada, Tsuyoshi; Yamaguchi, Yuichiro; Sato, Mototaka; Hatano, Koji; Mukai, Masatoshi; Nagahara, Akira; Oka, Daizo; Takayama, Hitoshi; Nishimura, Kazuo; Nonomura, Norio 分享 收藏 分享 收藏 Excision repair cross complementing group 1 (ERCC1) predicts the efficacy of chemoradiotherapy for invasive bladder cancerKawashima, Atsunari; Nakayama, Masashi; Kakuta, Yoichi; Abe, Toyofumi; Sato, Mototaka; Hatano, Koji; Mukai, Masatoshi; Nagahara, Akira; Oka, Daizo; Nakai, Yasutomo; Takayama, Hitoshi; Yoshioka, Toshiaki; Hoshida, Yoshihiko; Itatani, Hiroaki; Nishimura, Kazuo; Nonomura, Norio 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
